Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962.
about
Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.Autologous peripheral blood stem cell transplantation in children and adolescents with non-Hodgkin lymphoma.Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology GroupA prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma.Advances in hematopoietic stem cell transplantation in childhood and adolescent lymphomas.Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin's Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation StudyStratification of treatment intensity in relapsed pediatric Hodgkin lymphoma.Pulmonary complications of childhood cancers.Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation.Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed Hodgkin lymphoma.Outcome of autologous hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory Hodgkin's lymphoma.Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia.Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).Pharmacotherapeutic Management of Pediatric Lymphoma.Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry.Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model.
P2860
Q30248284-EA032D86-0079-4BDD-911C-5A1431FB0D34Q35669884-0C63155D-FCD3-41E1-AF9A-BD2CE7258FD4Q35944560-E2325A61-546F-4C65-A286-112E09989E4FQ36212381-5D56BA20-C327-4AB8-A033-8363CB889528Q36248964-B8A9DF8A-DECE-4B55-9904-1E689A0F3624Q36979074-2A10DE18-0A12-4771-9189-A0A6A54E4B9FQ37548240-B78E250A-39A2-452F-A92F-D841EB011183Q38185983-92407095-095D-460E-B22E-113AC01E2688Q38215237-69E066E8-FDAE-4401-9BE7-7C91396863B8Q38684561-0EA317A6-991E-44E7-93BF-358CCC6F83B3Q40695241-F0FEE910-5524-4255-8039-646EECC46BF0Q41265178-D86573D4-60C8-4FD5-93B1-A821C908F571Q41395870-D71B879C-CEC1-4CC9-A202-4EF7533F2310Q44198884-3AFD85B3-8C09-4942-AADB-D90CA2C997E6Q44647479-DA15CBDB-51B4-4BB4-B086-10B3CBC1EA2BQ47424276-D343B4AA-2602-4E7B-8F39-50D8A0D61753Q48321203-C13F5707-2672-454F-A52C-FEF5BFB0D3CEQ48341313-76C1DC2E-DF23-455F-8B90-FB2A16C23818Q50880574-DA4242BC-022D-4422-A3E2-A0F72541679CQ52668197-226C7FE0-D518-4085-856A-6176FBBD8B72
P2860
Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Autologous peripheral blood st ...... 's Oncology Group study A5962.
@ast
Autologous peripheral blood st ...... 's Oncology Group study A5962.
@en
Autologous peripheral blood st ...... 's Oncology Group study A5962.
@nl
type
label
Autologous peripheral blood st ...... 's Oncology Group study A5962.
@ast
Autologous peripheral blood st ...... 's Oncology Group study A5962.
@en
Autologous peripheral blood st ...... 's Oncology Group study A5962.
@nl
prefLabel
Autologous peripheral blood st ...... 's Oncology Group study A5962.
@ast
Autologous peripheral blood st ...... 's Oncology Group study A5962.
@en
Autologous peripheral blood st ...... 's Oncology Group study A5962.
@nl
P2093
P2860
P1476
Autologous peripheral blood st ...... 's Oncology Group study A5962.
@en
P2093
Adrianna Vlachos
Amanda M Termuhlen
James Lynch
Lauren Harrison
Lynette M Smith
Michael M Henry
Mitchell S Cairo
Phyllis Warkentin
Richard E Harris
Sherrie L Perkins
P2860
P304
P356
10.1016/J.BBMT.2010.07.002
P577
2010-07-15T00:00:00Z